TLR4 and myocardial infarction: Following SARS-CoV-2 infection, TLR4 activation on platelets may be associated with thrombotic events (such as myocardial infarction) in COVID-19 patients, and this thrombosis may affect the kidneys through cardio-renal syndrome.